• Dapps:16.23K
  • Blockchains:78
  • Active users:66.47M
  • 30d volume:$303.26B
  • 30d transactions:$879.24M

Polkadot and Avalanche: Potential for New Growth and Key Levels

user avatar

by Giorgi Kostiuk

10 months ago


The cryptocurrency market is buzzing with speculation about which digital assets might lead the next bullish wave. Recently, the focus has shifted to Polkadot and Avalanche. This article delves into the factors influencing their growth prospects.

Polkadot Market Snapshot: Recent Flows and Key Price Levels

Polkadot showed a weekly rise of 6.05% dampened by a 4.44% monthly dip and a 1.87% decrease over six months. It is trading within a range between $3.51 and $6.21 with resistance at $7.69 and support at $2.31. The RSI stands at 56.52, indicating moderate momentum.

AVAX Trading Snapshot: Mixed Momentum and Key Levels in Play

AVAX experienced a 7.92% monthly decrease and a 21.58% decline over six months, counterbalanced by a 20.51% weekly gain. Prices settle between $16.74 and $31.56, with support at $11.10 and resistance at $40.73. The RSI at 58.57 suggests trading without a strong trend.

Conclusion

Polkadot and Avalanche hold significant growth potential due to strong technical bases and active development communities. Market trends and increased adoption could further drive their prices up, with positive news and market performance boosting confidence in these coins.

Polkadot and Avalanche hold significant growth potential due to strong technical bases and active development communities. Market trends and increased adoption could further drive their prices up.

0

Rewards

chest
chest
chest
chest

More rewards

Discover enhanced rewards on our social media.

chest

Other news

Converge Bio's AI Platform Aims to Transform Drug Development

chest

Converge Bio is leveraging its newly acquired $25 million funding to enhance its AI platform, which focuses on drastically reducing the time and costs associated with drug development.

user avatarKenji Takahashi

Converge Bio Secures $25 Million Series A Funding to Transform Drug Discovery

chest

Converge Bio, a startup based in Boston and Tel Aviv, has raised $25 million in Series A funding to enhance AI-driven drug discovery.

user avatarMaria Fernandez

Buterin Continues Charity Donations from Token Sales

chest

Vitalik Buterin continues his practice of selling unsolicited tokens and donating the proceeds to charity, emphasizing ethical considerations in cryptocurrency promotions.

user avatarRajesh Kumar

Vitalik Buterin Sells Unsolicited Tokens for 94 ETH

chest

Ethereum cofounder Vitalik Buterin has sold unsolicited tokens from his wallet, converting them into 94 ETH.

user avatarGustavo Mendoza

Grayscale Segments Crypto Market into Five Vertical Categories

chest

Grayscale has categorized its altcoin candidates into five verticals, reflecting a structured approach to the crypto market.

user avatarMiguel Rodriguez

Decline in FLOW Price Amid Controversial Asset Recovery

chest

The price of FLOW has seen a significant decline following the Flow project's controversial asset recovery actions.

user avatarLuis Flores

Important disclaimer: The information presented on the Dapp.Expert portal is intended solely for informational purposes and does not constitute an investment recommendation or a guide to action in the field of cryptocurrencies. The Dapp.Expert team is not responsible for any potential losses or missed profits associated with the use of materials published on the site. Before making investment decisions in cryptocurrencies, we recommend consulting a qualified financial advisor.